Anton Rx Report

What do ‘ya get from a DNA modified pig? …………. wait for it………………..            ………….wait for it……………….. …………………..CRISPR BACON! 😊 DNA modification is about to trigger a

This week the FDA approved a new therapy, Qalsody (tofersen) from Biogen MA, Inc., for the treatment of amyotrophic lateral sclerosis (ALS) in adults who

Most would agree that the US has been a litigious-heavy country for decades. As we know, healthcare is one of the biggest targets for lawsuits of

The article below is one that a specialty pharmacy’s legal counsel might find most interesting. In short, the US District Court ruling below said that Humana

The FDA recently approved a therapy previously approved in 2021….. but with a very different indication and a new NDC. The approval was granted for Syfovre

Ever get a letter from more than 400 people?  Not 400 letters…. 1 letter with four hundred+ signatories! Over the last week more than 400 of

Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the press releases rarely

If you have you ever tried to explain all the nuances behind the host of decisions to launch a new specialty therapy through limited distribution, then

Walgreens has tripled down on acquisitions over the past year to the tune of several Billion $$$ in a quest to totally remodel the 122

In the old days (before the internet) the importance of a news item was often expressed in how many column inches the item was generating